Kite Pharma shares fly high on study results
August 25, 2014 at 17:29 PM EDT
Shares of biotech Kite Pharma surged nearly 50% in the extended session Monday after announcing 12 out of 13 patients taking its Non-Hodgkin’s Lymphoma treatment experienced some form of remission.
